Literature DB >> 33528564

ZIKA Virus Neutralizing Antibody Kinetics in Antenatally Exposed Infants.

Otavio de Melo Espindola1, Thomas Jaenisch2,3,4,5, Karin Nielsen-Saines6, Raquel de Vasconcellos Carvalhaes de Oliveira1, Boris Pastorino7, Zilton Vasconcelos8, Claudia Raja Gabaglia9, Ieda Pereira Ribeiro10, Denise Cotrim da Cunha11, Marcos Vinicius Pone8, Liege Maria Abreu de Carvalho8, Sheila Moura Pone8, Luana Damasceno1, Andrea Araujo Zin8, Myrna C Bonaldo10, Maria Elisabeth Lopes Moreira8, James D Cherry6, Xavier de Lamballerie7, Patrícia Brasil1.   

Abstract

BACKGROUND: Zika virus (ZIKV) is associated with severe congenital abnormalities and laboratory diagnosis of antenatal infection is difficult. Here we evaluated ZIKV neutralizing antibody (nAb) kinetics in infants born to mothers with PCR-confirmed ZIKV infection during pregnancy.
METHODS: Neonates (n = 98) had serum specimens tested repeatedly for ZIKV nAb over the first 2 years of life using virus neutralization test (VNT). ZIKV neonatal infection was confirmed by RT-PCR in blood or urine and/or presence of ZIKV IgM antibodies, and results were correlated with infant clinical features.
RESULTS: Postnatal laboratory evidence of ZIKV vertical transmission was obtained for 60.2% of children, while 32.7% exhibited clinical abnormalities. Congenital abnormalities were found in 37.3% of children with confirmed ZIKV infection and 31.0% of children without confirmed infection (P = .734). All but 1 child displayed a physiologic decline in ZIKV nAb, reflecting maternal antibody decay, despite an early ZIKV-IgM response in one-third of infants.
CONCLUSIONS: Infants with antenatal ZIKV exposure do not develop ZIKV nAb despite an early IgM response. Therefore, ZIKV VNT in children is not useful for diagnosis of congenital infection. In light of these findings, it remains to be determined if children infected in utero are potentially susceptible to reinfection.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Zika virus; biomarker; infection status; neutralizing antibodies; vertical transmission

Mesh:

Substances:

Year:  2021        PMID: 33528564      PMCID: PMC8448431          DOI: 10.1093/infdis/jiab054

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  Serologic Testing for Zika Virus: Comparison of Three Zika Virus IgM-Screening Enzyme-Linked Immunosorbent Assays and Initial Laboratory Experiences.

Authors:  Dane Granger; Heather Hilgart; Lori Misner; Jaime Christensen; Sarah Bistodeau; Jennifer Palm; Anna K Strain; Marja Konstantinovski; Dakai Liu; Anthony Tran; Elitza S Theel
Journal:  J Clin Microbiol       Date:  2017-04-26       Impact factor: 5.948

2.  Sequential Neuroimaging of the Fetus and Newborn With In Utero Zika Virus Exposure.

Authors:  Sarah B Mulkey; Dorothy I Bulas; Gilbert Vezina; Yamil Fourzali; Armando Morales; Margarita Arroyave-Wessel; Christopher B Swisher; Caitlin Cristante; Stephanie M Russo; Liliana Encinales; Nelly Pacheco; Youssef A Kousa; Robert S Lanciotti; Carlos Cure; Roberta L DeBiasi; Adre J du Plessis
Journal:  JAMA Pediatr       Date:  2019-01-01       Impact factor: 16.193

3.  Birth Defects Among Fetuses and Infants of US Women With Evidence of Possible Zika Virus Infection During Pregnancy.

Authors:  Margaret A Honein; April L Dawson; Emily E Petersen; Abbey M Jones; Ellen H Lee; Mahsa M Yazdy; Nina Ahmad; Jennifer Macdonald; Nicole Evert; Andrea Bingham; Sascha R Ellington; Carrie K Shapiro-Mendoza; Titilope Oduyebo; Anne D Fine; Catherine M Brown; Jamie N Sommer; Jyoti Gupta; Philip Cavicchia; Sally Slavinski; Jennifer L White; S Michele Owen; Lyle R Petersen; Coleen Boyle; Dana Meaney-Delman; Denise J Jamieson
Journal:  JAMA       Date:  2017-01-03       Impact factor: 56.272

4.  Zika Virus Infection in Pregnant Women in Rio de Janeiro.

Authors:  Patrícia Brasil; José P Pereira; M Elisabeth Moreira; Rita M Ribeiro Nogueira; Luana Damasceno; Mayumi Wakimoto; Renata S Rabello; Stephanie G Valderramos; Umme-Aiman Halai; Tania S Salles; Andrea A Zin; Dafne Horovitz; Pedro Daltro; Marcia Boechat; Claudia Raja Gabaglia; Patrícia Carvalho de Sequeira; José H Pilotto; Raquel Medialdea-Carrera; Denise Cotrim da Cunha; Liege M Abreu de Carvalho; Marcos Pone; André Machado Siqueira; Guilherme A Calvet; Ana E Rodrigues Baião; Elizabeth S Neves; Paulo R Nassar de Carvalho; Renata H Hasue; Peter B Marschik; Christa Einspieler; Carla Janzen; James D Cherry; Ana M Bispo de Filippis; Karin Nielsen-Saines
Journal:  N Engl J Med       Date:  2016-03-04       Impact factor: 91.245

5.  Loss of rubella hemagglutination inhibition antibody in congenital rubella. Failure of seronegative children with congenital rubella to respond to HPV-77 rubella vaccine.

Authors:  L Z Cooper; A L Florman; P R Ziring; S Krugman
Journal:  Am J Dis Child       Date:  1971-11

6.  Pregnancy Outcomes After Maternal Zika Virus Infection During Pregnancy - U.S. Territories, January 1, 2016-April 25, 2017.

Authors:  Carrie K Shapiro-Mendoza; Marion E Rice; Romeo R Galang; Anna C Fulton; Kelley VanMaldeghem; Miguel Valencia Prado; Esther Ellis; Magele Scott Anesi; Regina M Simeone; Emily E Petersen; Sascha R Ellington; Abbey M Jones; Tonya Williams; Sarah Reagan-Steiner; Janice Perez-Padilla; Carmen C Deseda; Andrew Beron; Aifili John Tufa; Asher Rosinger; Nicole M Roth; Caitlin Green; Stacey Martin; Camille Delgado Lopez; Leah deWilde; Mary Goodwin; H Pamela Pagano; Cara T Mai; Carolyn Gould; Sherif Zaki; Leishla Nieves Ferrer; Michelle S Davis; Eva Lathrop; Kara Polen; Janet D Cragan; Megan Reynolds; Kimberly B Newsome; Mariam Marcano Huertas; Julu Bhatangar; Alma Martinez Quiñones; John F Nahabedian; Laura Adams; Tyler M Sharp; W Thane Hancock; Sonja A Rasmussen; Cynthia A Moore; Denise J Jamieson; Jorge L Munoz-Jordan; Helentina Garstang; Afeke Kambui; Carolee Masao; Margaret A Honein; Dana Meaney-Delman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-06-16       Impact factor: 17.586

Review 7.  Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology.

Authors:  Lalita Priyamvada; William Hudson; Rafi Ahmed; Jens Wrammert
Journal:  Emerg Microbes Infect       Date:  2017-05-10       Impact factor: 7.163

8.  Vital Signs: Update on Zika Virus-Associated Birth Defects and Evaluation of All U.S. Infants with Congenital Zika Virus Exposure - U.S. Zika Pregnancy Registry, 2016.

Authors:  Megan R Reynolds; Abbey M Jones; Emily E Petersen; Ellen H Lee; Marion E Rice; Andrea Bingham; Sascha R Ellington; Nicole Evert; Sarah Reagan-Steiner; Titilope Oduyebo; Catherine M Brown; Stacey Martin; Nina Ahmad; Julu Bhatnagar; Jennifer Macdonald; Carolyn Gould; Anne D Fine; Kara D Polen; Heather Lake-Burger; Christina L Hillard; Noemi Hall; Mahsa M Yazdy; Karnesha Slaughter; Jamie N Sommer; Alys Adamski; Meghan Raycraft; Shannon Fleck-Derderian; Jyoti Gupta; Kimberly Newsome; Madelyn Baez-Santiago; Sally Slavinski; Jennifer L White; Cynthia A Moore; Carrie K Shapiro-Mendoza; Lyle Petersen; Coleen Boyle; Denise J Jamieson; Dana Meaney-Delman; Margaret A Honein
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-04-07       Impact factor: 17.586

9.  Delayed childhood neurodevelopment and neurosensory alterations in the second year of life in a prospective cohort of ZIKV-exposed children.

Authors:  Karin Nielsen-Saines; Patrícia Brasil; Tara Kerin; Zilton Vasconcelos; Claudia Raja Gabaglia; Luana Damasceno; Marcos Pone; Liege M Abreu de Carvalho; Sheila M Pone; Andrea A Zin; Irena Tsui; Tania Regina S Salles; Denise Cotrim da Cunha; Roozemerie Pereira Costa; Jociele Malacarne; Ana Beatriz Reis; Renata Hydee Hasue; Carolina Y P Aizawa; Fernanda F Genovesi; Christa Einspieler; Peter B Marschik; José Paulo Pereira; Stephanie L Gaw; Kristina Adachi; James D Cherry; Zhiheng Xu; Genhong Cheng; Maria Elisabeth Moreira
Journal:  Nat Med       Date:  2019-07-08       Impact factor: 53.440

10.  Isolation of Infective Zika Virus from Urine and Saliva of Patients in Brazil.

Authors:  Myrna C Bonaldo; Ieda P Ribeiro; Noemia S Lima; Alexandre A C Dos Santos; Lidiane S R Menezes; Stephanie O D da Cruz; Iasmim S de Mello; Nathália D Furtado; Elaine E de Moura; Luana Damasceno; Kely A B da Silva; Marcia G de Castro; Alexandra L Gerber; Luiz G P de Almeida; Ricardo Lourenço-de-Oliveira; Ana Tereza R Vasconcelos; Patrícia Brasil
Journal:  PLoS Negl Trop Dis       Date:  2016-06-24
View more
  2 in total

Review 1.  Role of aging in Blood-Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19.

Authors:  Daniel Adesse; Luis Gladulich; Liandra Alvarez-Rosa; Michele Siqueira; Anne Caroline Marcos; Marialice Heider; Caroline Soares Motta; Silvia Torices; Michal Toborek; Joice Stipursky
Journal:  Fluids Barriers CNS       Date:  2022-08-18

2.  Clinical phenotype in infants with negative Zika virus immunoglobulin M testing born to mothers with confirmed Zika virus infection during pregnancy.

Authors:  Shana Godfred-Cato; Suzanne Newton; Laura Adams; Miguel Valencia-Prado; Heather Lake-Burger; Andrea Morrison; Abbey M Jones; Samantha M Olson; Nicole M Roth; Van T Tong; Suzanne M Gilboa; Dana Meaney Delman; Margaret A Honein; Jennifer Erin Staples; Cynthia A Moore
Journal:  Birth Defects Res       Date:  2021-07-30       Impact factor: 2.661

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.